OpenBilldrug price receipt

NADAC week of 2026-10-14

METHOCARBAMOL 750 MG TABLET

For 30 tablets

Pharmacies pay

$1.29 filed

30 × $0.04311 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$4.61 filed

30 × $0.15377 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.6× estimated

Medicare paid 3.6× what pharmacies pay.

Part D averages every strength and form sold under “Methocarbamol*” / “Methocarbamol” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.48 estimated

$1.29 + $0.19 (15%) + $5.00 fee per fill = $6.48

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

METHOCARBAMOL 750 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “methocarbamol” and “methocarbamol tablets”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Methocarbamol Tablets, USP, 750 mg”.

FDA gives its dosage form as “tablet”, “tablet, film coated” and “tablet, coated” and its route as oral.

FDA lists 10 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Camber Pharmaceuticals, Inc. and Solco Healthcare LLC.

FDA’s Established Pharmacologic Class for it is Muscle Relaxant.

The NADAC file of 2026-10-14 prices it under 20 NDCs (National Drug Codes); the FDA directory lists 18 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.29 for 30 tablets (30 × $0.04311 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 10 labelers

LabelerNDCsPharmacies pay per unit
Oxford Pharmaceuticals, LLC3$0.04311 per EA filed
Aurobindo Pharma Limited2$0.04311 per EA filed
Camber Pharmaceuticals, Inc.2$0.04311 per EA filed
Granulation Technology, Inc.2$0.04311 per EA filed
Granules Pharmaceuticals Inc.2$0.04311 per EA filed
Solco Healthcare LLC2$0.04311 per EA filed
UNICHEM PHARMACEUTICALS (USA), INC.2$0.04311 per EA filed
American Health Packaging1$0.04311 per EA filed
AvPAK1$0.04311 per EA filed
Major Pharmaceuticals1$0.04311 per EA filed
Not listed as a package in the FDA directory2$0.04311 per EA filed
All 20 NDCs, with labeler and price
  • 00904-7058-61 · Major Pharmaceuticals · $0.04311 per EA · eff. 2026-09-23 filed
  • 31722-0534-01 · Camber Pharmaceuticals, Inc. · $0.04311 per EA · eff. 2026-09-23 filed
  • 31722-0534-05 · Camber Pharmaceuticals, Inc. · $0.04311 per EA · eff. 2026-09-23 filed
  • 43547-0226-10 · Solco Healthcare LLC · $0.04311 per EA · eff. 2026-09-23 filed
  • 43547-0226-50 · Solco Healthcare LLC · $0.04311 per EA · eff. 2026-09-23 filed
  • 50268-0521-11 · not listed as a package in the FDA directory · $0.04311 per EA · eff. 2026-09-23 filed
  • 50268-0521-15 · AvPAK · $0.04311 per EA · eff. 2026-09-23 filed
  • 59651-0341-01 · Aurobindo Pharma Limited · $0.04311 per EA · eff. 2026-09-23 filed
  • 59651-0341-05 · Aurobindo Pharma Limited · $0.04311 per EA · eff. 2026-09-23 filed
  • 60687-0568-01 · American Health Packaging · $0.04311 per EA · eff. 2026-09-23 filed
  • 60687-0568-11 · not listed as a package in the FDA directory · $0.04311 per EA · eff. 2026-09-23 filed
  • 63561-0174-01 · Granulation Technology, Inc. · $0.04311 per EA · eff. 2026-09-23 filed
  • 63561-0174-05 · Granulation Technology, Inc. · $0.04311 per EA · eff. 2026-09-23 filed
  • 69584-0612-10 · Oxford Pharmaceuticals, LLC · $0.04311 per EA · eff. 2026-09-23 filed
  • 69584-0612-50 · Oxford Pharmaceuticals, LLC · $0.04311 per EA · eff. 2026-09-23 filed
  • 69584-0612-90 · Oxford Pharmaceuticals, LLC · $0.04311 per EA · eff. 2026-09-23 filed
  • 70010-0770-01 · Granules Pharmaceuticals Inc. · $0.04311 per EA · eff. 2026-09-23 filed
  • 70010-0770-05 · Granules Pharmaceuticals Inc. · $0.04311 per EA · eff. 2026-09-23 filed
  • 76385-0124-01 · UNICHEM PHARMACEUTICALS (USA), INC. · $0.04311 per EA · eff. 2026-09-23 filed
  • 76385-0124-50 · UNICHEM PHARMACEUTICALS (USA), INC. · $0.04311 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share an FDA nonproprietary name with METHOCARBAMOL 750 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
METHOCARBAMOL 1,000 MG TABLET
generic · tablet, coated
$8.348 per EA filed
eff. 2026-05-20
$0.15377 per EA filed
Part D 2024 average
METHOCARBAMOL 500 MG TABLET
generic · tablet / tablet, film coated / tablet, coated
$0.03946 per EA filed
eff. 2026-09-23
$0.15377 per EA filed
Part D 2024 average
METHOCARBAMOL 750 MG TABLET this page
generic · tablet / tablet, film coated / tablet, coated
$0.04311 per EA filed
eff. 2026-09-23
$0.15377 per EA filed
Part D 2024 average
TANLOR 1,000 MG TABLET
generic · tablet, film coated
$8.348 per EA filed
eff. 2026-05-20
$19.3471 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 20 NDCs’ NADAC prices is $0.04311 per EA filed.

Of the 22 other products in FDA’s Muscle Relaxant class priced per EA, 19 have a higher middle NADAC price and 3 a lower one. The one in the middle is CHLORZOXAZONE 375 MG TABLET, at $0.66652 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $4.61 for 30 tablets, at an average of $0.15377 per EA in 2024 (2024-01-01 to 2024-12-31) for “Methocarbamol*” and “Methocarbamol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 3,190,991 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for METHOCARBAMOL 750 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Methocarbamol* / Methocarbamol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. All 42 NADAC NDCs the name join matched to it have an FDA route including ORAL. 4 of the 42 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code).